Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features
Hematology in Clinical Practice · 2022
DOI: 10.5603/hcp.2022.0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2022. Verfasst von Elżbieta Patkowska und 3 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Patkowska, E., Prochorec-Sobieszek, M., Lech-Marańda, E., & Nasiłowska-Adamska, B. (2022). Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2022.0004
Vancouver
Patkowska E, Prochorec-Sobieszek M, Lech-Marańda E, Nasiłowska-Adamska B. Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features. Hematology in Clinical Practice. 2022. doi:10.5603/hcp.2022.0004
BibTeX
@article{Patkowska2022,
author = {Patkowska, Elżbieta and Prochorec-Sobieszek, Monika and Lech-Marańda, Ewa and Nasiłowska-Adamska, Barbara},
title = {Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features},
journal = {Hematology in Clinical Practice},
year = {2022},
doi = {10.5603/hcp.2022.0004}
}
EUVIMED